Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 Antibodies to MDA–apoB-100 Peptides Block oxLDL-Induced Monocyte MCP-1 Production In Vitro

(A) MCP-1 levels in conditioned medium from monocytes incubated with titrated concentrations of IEI-E3 (shaded squares), 2D03 (solid squares), or FITC-8 control IgG1 (open squares) in the presence of oxLDL-containing human serum. The graph shows mean ± SD of triplicate values from a representative experiment. (B) MCP-1 messenger ribonucleic acid (mRNA) relative to 18S mRNA levels in human monocytes incubated with 60 µg/ml 2D03, IEI-E3, or FITC-8 in the presence of oxLDL-containing human serum. Graphs show mean ± SD of triplicate values using cells obtained from 3 different donors (n = 9). ***p < 0.001 versus FITC-8. IgG = immunoglobulin G; MCP = monocyte chemoattractant protein; oxLDL = oxidized low-density lipoprotein; other abbreviations as in Figure 2.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement